Download PDF

Other users also viewed these articles

Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis? Ana Martins; Sofia Pimenta; Daniela Oliveira; Rafaela Nicolau; Alexandra Bernardo; Teresa Martins Rocha; Lúcia Costa; Miguel Bernardes;
Reumatol Clin. 2024;20:380-5
Raoul Dufy: Color and resilience in the fight against rheumatoid arthritis Fernando Canillas; Marta Canillas;
10.1016/j.reumae.2025.501847
Agreement between cardiovascular risk scores in a high-altitude Andean population with rheumatoid arthritis Carlos Diaz-Arocutipa; Vidia Lumbe-Diaz; Percy Soto-Becerra;
Reumatol Clin. 2025;21: